وزارة الصحة الفلسطينية - الإدارة العامة للصيدلة
|Updated Palestinian EDL and CDL 17-8-2020 |
| |
|1. ANAESTHETICS |
| |1.1.1 Inhalational medicines |
|M-011-0050 |sevoflurane |100% vial |
|M-011-0002 |Isoflurane |Inhalation 100 ml liquid |
|E01108224 |Nitrous oxide |Inhalation |
|E01108228 |Oxygen |Inhalation (medicinal gas) |
| |1.1.2 Injectable medicines |
|M-011-0005 |Ketamine (as hydrochloride) |Injection: 50 mg /ml in 10‐ml vial |
|M-011-0020 |Propofol |Injection: 10 mg/ml |
|M-011-0025 |Thiopental Sodium |Vial: 1 gm |
| |1.2 Local Anesthetics |
|M-012-0003 |Bupivacaine |Vial: 0.5% |
|M-012-0015 |Bupivacaine Hydrochloride |Injection for spinal anesthesia: 0.5% in 4‐ml |
| | |amp to be mixed with 7.5% glucose solution |
|M-012-0020 |Lidocaine HCl |Injection: 1%. 10 mL |
|M-012-0025 |Lidocaine HCl |Injection: 2%. 10 mL |
|M-012-5005 |Lidocaine HCl |Jelly: 2%. 30 Grams |
|M-012-0030 |Lidocaine HCl |Injection: 4%. 10 mL |
|M-012-0044 |Lidocaine HCl + Epinephrine (adrenaline) |CART: 2% + 1:200000 in vial |
|M-012-0043 |Lidocaine 3% without adrenaline |1.8ml carpule |
|M-251-0010 |Ephedrine HCl |CART: 50 mg/ml in 1‐ml ampoule |
| |1.3 Preoperative medication and sedation for short-term procedures |
|M-011-0015 |Midazolam |Injection (IV, IM): 5mg /5ml. |
|M-022-9015 |Morphine |Injection: 10 mg in 1 ml ampoule |
|M-032-0005 |Atropine Sulfate |Injection: 1 mg in 1‐ml ampoule |
|2. Analgesics, Antipyretics, Non-Steroidal Anti-Inflammatory Drugs (NSAIDS), Medicines Used To Treat Gout And Disease Modifying |
|Agents In Rheumatoid Disorders (DMARDS) |
| |2.1 Non-opioids and non-steroidal anti-inflammatory medicines (NSAIMs) |
|M-021-0010 |Diclofenac |Injection: 75 mg |
|M-021-1100 |Diclofenac |Tablet: 50 mg ( Sod OR Pot) |
|M-021-1025 |Ibuprofen |Tablet: 400 mg |
|M-021-2003 |Ibuprofen |Suspension: 100 mg / 5 mL |
|M-021-6010 |Indomethacin |Suppository: 100 mg |
|M-021-2004 |Paracetamol |Oral liquid: 125 mg/5 ml suspension |
|M-021-1030 |Paracetamol |Tablet: 500 mg |
|M-021-6015 |Paracetamol |150 mg suppository |
|M-021-0026 |paracetamol |1000 mg vial |
| |2.2 Opioid analgesics |
|M-022-9005 |Fentanyl |Injection: 0.05 mg/ml. 2ml amp |
|M-022-9010 |Fentanyl |Injection: 0.05 mg/ml. 10 ml amp |
| |Fentanyl |Transdermal patch50(mcg/hr and |
| | |25 mcg/hr release rate) |
|M-022-9015 |Morphine Sulphate |Injection: 10 mg in 1ml ampoule |
|M-022-9020/25 |Morphine Sulphate |Tablet (prolonged release): 10 mg; 30 mg |
|M-022-9027 |Morphine Sulphate |Tablet(immediate release):15mg |
|M-022-9031 |Oxycodone HCL + Paracetamol |Tablet : 5 mg + 325 mg |
|M-022-9034 |Oxycodone HCL |Syrup: 2 mg /1 ml |
|M-022-9050/45 |Pethidine |Injection: 50 mg; 100 mg |
| |2.3 Medicines used to treat gout |
|M-023-1005 |Allopurinol |Tablet: 100 mg |
|M-023-1010 |Colchicine |Tablet: 0.5 mg |
| |2.4 Disease modifying agents used in rheumatoid disorders (DMARDs) |
|M-105-1005 |Azathioprine |Tablet: 50 mg |
|M-083-1010 |Hyroxychloroquine |Tablet: 200 mg |
|M-101-1035 |Methotrexate |Tablet: 2.5 mg (as sodium salt) |
|M-032-1005 | Penicillamine |Solid oral dosage form: 250 mg |
|3. Antiallergics And Medicines Used In Anaphylaxis |
|M-041-1005 |Chlorpheneramine Maleate |Tablet: 2 mg |
|M-041-2006 |Chlorpheneramine Maleate |Syrup: 2 mg/ 5 mL. 60 mL bottle |
|M-195-0005 |Dexamethasone |Injection: 4 mg in1‐ml ampoule. |
|M-195-1005 |Dexamethasone |Tablet: 0.5mg |
|M-125-0005 |Epinephrine (adrenaline) |Injection: 1 mg in 1‐ml ampoule |
|M-125-0022 |Noradrenalin |4 mg ampoule |
|M-195-0015 |Hydrocortisone |Powder for injection: 100 mg in vial |
|M-041-1030 |Loratidine |Tablet: 10 mg |
|M-195-1025/0 |Prednisolone |Tablet: 5mg, 20 mg |
|M-041-2036 |Promethazine |Syrup: 5 mg /5 ml |
|4. Antidotes And Other Substances Used In Poisonings |
| |4.1 Non-specific |
|M-031-2005 |Charcoal, activated |Powder 25gm |
| |4.2 Specific |
|M-032-0001 |N-Acetylcysteine |Injection: 20%. 10 mL |
|M-032-0005 |Atropine |Injection: 1 mg (sulfate) in 1‐ml ampoule |
|M-032-1004 |Deferasirox |Tablet: 500 mg |
|M-032-1001 |Deferasirox |Tablet: 250 mg |
|M-032-0035 |Deferoxamine |Powder for injection: 500 mg (mesylate) in vial|
|M-032-0010 |Flumazenil |Injection: 0.5 mg/ml |
|M-032-0015 |Methylene Blue |Injection: 1%. |
|M-032-9010 |Naloxone |Injection: 0.4 mg/ mL in 1‐ml ampoule |
|M-032-0020 |Neostigmine methylsulphate |Injection: 2.5 mg |
|M-032-0025 |Obidoxime chloride |Injection |
|M-032-1005 |Penicillamine |Solid oral dosage form: 250 mg |
|5. Anticonvulsants/Antiepileptics |
|M-051-2005 |Carbamazepine |Oral liquid: 2% syrup (250 mL) |
|M-051-1008 |Carbamazepine |Tablet: 200 mg CR |
|M-051-1005 |Carbamazepine |Tablet: 200 mg scored regular tablet |
|M-051-1010 |Clonazepam |Tablet: 2 mg |
|M-051-3005 |Clonazepam |Drops: 2.5 mg/ ml. 10 ml |
|M-051-1019 |Lamotrigine |Tablet: 25 mg |
|M-051-1022 |Lamotrigine |Tablet: 100 mg |
|M-292-0007 |Magnesium sulfate | Injection: 50% |
|M-241-1015 |Phenobarbital |Tablet: 15 mg |
|M-241-1107 |Phenobarbital |Tablet: 100 mg |
|M-241-0036 |Phenobarbital |Vial: 200 mg, 1 ml |
|M-051-1025 |Phenytoin Sodium |Capsule: 100 mg |
|M-051-0005 |Phenytoin Sodium |Vial: 250 mg. 5 mL |
|M-051-1038/40 |Topiramate |Tablet: 25 mg, 100 mg |
|M-051-1035 |Valproic acid (sodium valproate) |Tablet (enteric‐coated): 200 mg |
|M-051-2010 |Valproic acid (sodium valproate) |Oral liquid: 200 mg/5 ml |
|M-051-1037 |sodium valproate 333 mg + valproic acid 145 mg |chrono tablet |
|M-051-1045 |Vigabatrin |Tablet: 500 mg |
|6. Anti-Infective Medicines |
| |6.1 Anthelminthics |
| |6.1.1 Intestinal anthelminthics |
|M-083-1005 |Albendazole |Tablet: 400 mg |
|M-083-1025 |Mebendazole |Tablet (chewable): 100 mg |
|M-083-2010 |Mebendazole |Oral Liquid (Suspension):100 mg/5ml. 30 ml |
| |6.1.2 Antifilarials |
|M-083-1005 |Albendazole |Tablet: 400 mg |
| |6.2 Antibacterials |
| |6.2.1 Beta Lactam medicines |
|M-081-2028 |Amoxycillin |Powder for oral liquid: 400 mg (as trihdrate)/5|
| | |ml |
|M-081-1015 |Amoxycillin |Capsule: 500 mg |
|M-081-1009 |Amoxycillin + Clavulanic acid |Tablet: 500 mg + 125 mg |
|M-081-2039 |Amoxycillin + Clavulanic acid |Oral Liquid (Suspension):400 mg +57 mg (salt) |
| | |powder. |
|M-081-0010 |Amoxycillin+ Clavulanic acid |I.V injection |
|M-081-0020 |Ampicillin |Powder for injection: 1 g in vial. |
|M-081-0120 |Benzathine Benzylpenicillin |Powder for injection: 900 mg benzylpenicillin |
| | |(= 1.2 million IU) |
| | |in 5 -ml. |
|M-081-0095 |Benzylpenicillin |Injection: 10 million IU |
|M-081-2005 |Cefalexin |Suspension (Powder for reconstitution with |
| | |water): 250 mg/5 mL. 100 mL |
|M-081-1040 |Cefalexin |Capsule : 500 mg |
|M-081-0030 |Cefazolin Sodium |Vial: 1 g (as sodium salt) in vial |
|M-081-0037 |Cefotaxime Sodium |Vial: 250 mg |
|M-081-0045 |Ceftriaxone Sodium |Powder for injection: 1 g in vial |
|M-081-0050 |Cefuroxime sodium |Injection: 750 mg/ vial. |
|M-081-1020 |Cefuroxime sodium |Tablet or capsule: 250 mg |
|M-081-1030 |Cefuroxime sodium |Tablet : 500 mg |
|M-081-0040 |Ceftazidime |Injection: 1g/vial |
|M-081-0070 |Cloxacillin Sodium |Injection: 500 mg in a vial |
|M-081-2055 |Cloxacillin Sodium |Suspension: 250 mg/5 ml. |
|M-081-1053 |Cloxacillin Sodium |Capsule: 500 mg |
|M-081-0079 |Meropenem |Injection: 1 gm in a vial |
|M-081-2015 |Phenoxymethyl penicillin (Pen. V) |Powder for oral liquid: 250 mg (as potassium |
| | |salt)/5 ml |
|M-081-1090 |Phenoxymethyl penicillin (Pen. V) |Tablet: 500 mg |
|M-081-0113 |Piperacillin-tazobactam |Injection :4 g ? |
| |6.2.2 Other antibacterials |
|M-081-0005 |Amikacin sulphate |Injection: 500 mg |
|M-081-1018 |Azithromycin |Capsule: 250 mg |
|M-081-2003 |Azithromycin |Oral liquid: 200 mg/5 ml |
|M-081-0055 |Chloramphenicol |Powder for injection: 1 g in vial |
|M-081-1045 |Ciprofloxacin |Tablet: 250 mg |
|M-081-1050 |Ciprofloxacin |Tablet: 500 mg |
|M-081-0060 |Ciprofloxacin |Injection 200 mg/vial |
|M-081-0065 |Clindamycin |Injection: 600 mg |
|M-081-1055 |Doxycycline |Cap: 100 mg |
|M-081-2010 |Erythromycin |Suspension: 200 mg/5 ml. 100 mL |
|M-081-0071 |Erythromycin lactobionate |Amp: 500 mg |
|M-081-1060 |Erythromycin |Tablet: 250 mg |
|M-081-0075 |Gentamicin |Injection: 80 mg/ vial |
|M-081-0080 |Metronidazole |Injection: 500 mg in 100‐ml vial. |
|M-083-2005 |Metronidazole |Suspension: 125mg/5ml |
|M-083-1015-13 |Metronidazole |Tablet: 250 mg, 500 mg |
|M-081-2045 |Nalidixic acid |Suspension: 250 mg/ mL; 100 mL |
|M-081-2025 |Sulfamethoxazole +Trimethoprim |Suspension: 200 mg + 40 mg/5ml |
|M-081-1110 |Sulfamethoxazole + Trimethoprim | |
| | |Tablet: 400 mg + 80 mg |
|M-081-1111 |Sulfamethoxazole+ Trimethoprim |Tablet: 800 mg + 160 mg |
|M-081-0141 |Teicoplanin |Injection: 200 mg/vial |
|M-081-0115 |Vancomycin |Injection : 500 mg in vial |
|M-081-1074 |Levofloxacin |Tablet: 500 mg |
|M-081-0081 |Levofloxacin |Infusion Vial: 500mg/100ml |
| |6.2.3 Antileprosy medicines |
|M-081-1095 |Rifampicin |Capsule: 300mg |
| |6.2.4 Antituberculosis medicines |
|M-081-1065 |Ethambutol |Tablet: 400 mg (hydrochloride) |
|M-081-1114 |Isoniazid |Tablet (scored): 100 mg |
|M-081-1025 |Pyrizinamide |Tablet: 500 mg |
|M-081-1095 |Rifampicin |Solid oral dosage form: 300 mg |
|M-081-2024 |Rifampicin |Syrup 2% 120 ml |
|M-081-0110 |Streptomycin Sulphate |Powder for injection: 1 g in vial |
|M-081-1107 |Ethambutol + Isoniazid + Pyrazinamide |Tablet: 275 mg + 75 mg + 400 mg + 150 mg. |
| |+ Rifampicin | |
|M-081-1103 |Rifampicin + Isoniazide + Ethambutol |Tablet: 150 mg + 75 mg + 275 mg |
|M-081-1107 |Rifampicin + Isoniazid + Pyrazinamide |Tablet: 60 mg + 30 mg + 150 mg |
|M-081-1101 |Rifampicin + Isoniazid |Tablet: 60 mg + 30 mg. |
|M-081-1108 |Rifampicin + Isoniazid |Tablet: 150 mg + 75 mg. |
| |6.3 Antifungal drugs |
|M-082-0005 |Amphotericin B |Powder for injection: 50 mg in vial |
|M-083-1035 |Fluconazole |Tablet: 50 mg |
|M-082-0015 |Fluconazole |Injection: 2 mg/ml in vial |
|M-082-1005 |Griseofulvin |Tablet: 125 mg |
|M-082-2002 |Griseofulvin |Oral liquid: 125 mg/5 ml |
|M-083-1027 |Miconazole nitrate |Vaginal tablet:400 mg |
|M-082-2005 |Nystatin |Oral liquid: 100 000 IU/ml. 12 mL |
| |6.4 Antiviral medicines |
| |6.4.1 Antiherpes medicines |
|M-085-2005 |Acyclovir |Oral liquid: 200 mg/5 ml |
|M-085-1006 |Acyclovir |Tablet: 400 mg |
|M-085-0010 |Acyclovir |Injection: 250 mg /vial |
| |6.4.2 Antiretrovirals |
| |6.4.2.1 Nucleoside/Nucleotide reverse transcriptase inhibitors |
|M-085-1001 |Abacavir (ABC) |Tablet: 300 mg (as sulfate) |
|E06402205 |Didanosine (ddI) |Capsule : 125,200,250,400mg |
|E06402210 |Emtricitabine (FTC) |Capsule: 200 mg |
|M-085-1030 |Lamivudine (3TC) |Tablet: 150 mg. |
|E06402226 |Stavudine (d4T) |Capsule: 15 ,20,30,40mg |
|M-085-1072 |Tenofovir Disoproxil Fumarate (TDF)[C] |Tablet: 300 mg |
|E06402124 |Zalcitabine |Tablet: 0.75mg |
|E06402228 |Zidovudine (ZDV or AZT) |Capsule: 100 mg |
| |6.4.2.2 Protease inhibitors |
|E06402216 |Indinavir (IDV) |Tablet: 400 mg |
|E06402120 |Nelfinavir |Tablet: 250 mg |
|M-085-1012 |Ritonavir |Tablet: 100 mg |
|E06402224 |Saquinavir (SQV) |Capsules: 200 mg |
| |6.4.2.3 Non-Nucleoside/Nucleotide reverse transcriptase inhibitors |
|E06402114 |Efavirenz |Capsule:50,100,200 mg |
| |6.4.3. FIXED-DOSE COMBINATIONS |
|E06402116 |Efavirenz + Emtricitabine + Tenofovir |Tablet: 600 mg + 200 mg + 300 mg |
|M-085-1075 |Emtricitabine + Tenofovir |Tablet: 200 mg + 300 mg |
|E06402221 |Lopinavir + Ritonavir (LPV/r) |Capsule: 133.3 mg + 33.3 mg |
|M-085-1032 |Zidovudine+Lamivudine |Tablet: 300mg +150 mg |
|E06402129 |Zidovudine + Lamivudine + Nevirapine |Tablet: 300mg+ 150 mg + 200 mg. |
|E06402126 |Stavudine+ Lamivudine+ Nevirapine |Tablet: 30 mg+ 150 mg+ 200 mg |
| |6.4.4 Anti hepatitis Medicine |
|M-085-1009 |Adefovir Dipivoxil |Tablet : 10 mg |
|M-101-0096 |Peginterferon alfa- 2A |Injection: 180 mcg/ml |
|M-085-1013 |Ribavirin |Solid oral dosage form: 200 mg |
|M-085-1072 |Tenofovir Disoproxil Fumarate (TDF)[C] |Tablet: 300 mg |
|M-085-1029 |Lamivudine |100 mg tab |
|M-085-1090 |Entecavir |Tablet : 1mg |
|M-085-1095 |Sofosbuvir+ledipasvir |Tablet : 400mg + 90mg |
| |6.5 Antiprotozoal medicines |
| |6.5.1 Antiamoebic and antigiardiasis medicines |
|M-083-1015 |Metronidazole |Tablet: 250 mg |
|M-083-2005 |Metronidazole |Oral liquid: 125 mg /5 ml |
| |6.5.2 Antileishmaniasis medicines |
| |Meglumine antimoniate |Solution: 100 mg/ml injection |
| | |(1.5 gram meglumine antimoniate equivalent to |
| | |425 mg of pentavalent antimony) |
| |6.5.3 Antimalarial medicines |
|M-083-1010 |Hydroxychloroquine as phosphate or sulfate |Tablet:200 mg |
| |6.5.4 Antipneumocystosis and antitoxoplasmosis medicines |
|M-081-2025 |Sulfamethoxazole + Trimethoprim |Oral liquid: 200 mg + 40 mg/5 ml |
|M-081-1110 |Sulfamethoxazole + Trimethoprim |Tablet: 400 mg + 80 mg |
|M-081-1111 |Sulfamethoxazole + Trimethoprim |Tablet: 800 + 160 mg |
|7. Antimigraine Medicines |
| |7.1 For treatment of acute attack |
|M-021-1030 |Paracetamol |Tablet: 500 mg. |
| |7.2 For prophylaxis |
|M-121-1045 |Propranolol |Tablet: 40 mg (hydrochloride) |
|8. Antineoplastic, Immunosuppressives And Medicines Used In Palliative Care |
| |8.1 Immunosuppressive and Immunostimulants |
|M-105-1005 |Azathioprine |Tablet (scored): 50 mg |
|M-105-1010 |Cyclosporin |Capsule: 25 mg |
|M-105-1015 |Cyclosporin |Capsule: 50 mg |
|M-105-2005 |Cyclosporin |Solution: 100 mg /ml. 50 mL |
|M-105-1020 |Cyclosporin |Capsule: 100 mg |
|M-105-1030 |Mycophenolate Mofetil |Tablet: 500 mg |
|M-105-1031 |Mycophenolate sodium |Tablet:360mg |
|M-105-1025 |Tacrolimus |Capsule: 1mg |
|M-105-1026 |Tacrolimus |Capsule: 5mg |
|M-101-0057 |Interferon beta - 1A 30 mcg |Vial |
|M-101-0104 |Interferon beta - 1A 44 mcg |Vial |
| |8.2 Cytotoxic and adjuvant medicines |
|M-101-0005 |5-Flourouracil |Injection: 1 gram in vial |
|M-101- |Peg-Asparaginase |Powder for injection: 3750 IU/5ml in vial |
|M-101-0010 |Actinomycin D |Injection: 0.5 mg |
|M-101-0015 |Doxorubicin |Injection: 10 mg |
|M-101-0020 |Doxorubicin |Injection: 50 mg |
|M-101-0022 |BCG Tice 5x |Injection |
|M-101-0025 |Bleomycin |Powder for injection: 15 I.U in vial |
|M-281-1030 |Calcium folinate |Tablet: 15 mg |
|M-281-0010 |Calcium folinate |Injection: 50 mg / vial |
|M-101-1006 |Capecitabine |Tablet: 500 mg |
|M-101-0027 |Carboplatin |Injection: 10 mg/ml. 45 mL |
|M-101-0003 |Carmustine 100 mg |Vial: 100 mg |
|M-101-1005 |Chlorambucil |Tablet: 2 mg |
|M-101-0030 |Cisplatinum |Injection: 50 mg /vial |
|M-101-0031 |Cisplatinum |Injection: 10 mg /vial |
|M-101-0035 |Cyclophosphamide |Powder for injection: 500 mg in vial |
|M-101-1010 |Cyclophosphamide |Tablet: 50 mg |
|M-101-0040 |Cytarabine |Powder for injection: 100 mg in vial |
|M-101-0047 |Dacarbazine |Powder for injection: 200 mg in vial |
|M-101-0045 |Daunorubicin |Injection: 20 mg in vial |
|M-101-0051 |Docetaxel |Vial: 20 mg |
|M-101-0052 |Docetaxel |Vial: 80 mg |
|M-101-0112/1 |Epirubicin HCL |Vial: 10 mg; 50 mg |
|M-101-0055 |Etoposide |Injection: 100 mg /5 ml |
|M-101-0064 |Fludarabine |Injection :50 mg /vial |
|M-104-0005 |Filgrastim |Injection: 300 mcg/ml. |
|M-101-0056 |Gemcitabine |Injection: 1 g/vial |
|M-101-1020 |Hydroxyurea |Capsule: 500 mg |
|M-101-1018 |Imatinib |Tablet: 400 mg |
|M-101-1038 |Nilotinib |Cap 200 mg |
|M-101-0060 |Interferon alpha- 2A |Injection: 3 million I.U |
|M-101-0102 |Isofosfamide |Vial: 2 gm |
|M-101-0062 |Irinotecan hcl |100 mg/5ml |
|M-101-0066 |Irinotecan hcl |300 mg/15 ml |
|M-101-1025 |Megestrol acetate |Tablet: 40 mg |
|M-101-0070 |Methotrexate Sodium |Powder for injection: 50 mg in vial |
|M-101-1035 |Methotrexate Sodium |Tablet: 2.5 mg |
|M-101-0075 |Methotrexate |Injection: 500 mg /vial |
|M-101-1030 |Melphalan |Tablet : 2 mg |
|M-101-1021 |Mercaptopurine |Tablet: 50 mg |
|M-101-0101 |Mesna |Vial: 400 mg |
|M-101-0080 |Mitomycin |Injection : 10 mg /vial |
|M-101-0090 |Mitoxantrone |Injection: 20 mg /vial |
|M-101-0106 |Oxaliplatin |Vial: 50 mg |
|M-101-0107 |Oxaliplatin |Vial: 100 mg |
|M-101-0089 |Paclitaxel |100 mg vial |
|M-101-0091 |Paclitaxel |300 mg vial |
|M-101-0121 |Zoledronic Acid |Vial: 4mg vial |
|M-101-1045 |Thioguanine |Tablet: 40 mg. |
|M-101-0100 |Vinblastine Sulphate |Powder for injection: 10 mg in vial |
|M-101-0105 |Vincristine Sulphate |Powder for injection: 1 mg in vial |
|M-101-0002 |Vinorelbine |Amp: 50 mg |
| |8.3 Hormones and Anti-hormones |
|M-102-1001 |Bicalutamide |Tablet: 50 mg |
|M-101-1022 |Letrozole |Tablet: 2.5 mg |
|M-102-1015 |Tamoxifen |Tablet: 20 mg (as citrate) |
|M-103-0012 |Goserelin |Ampoule : 3.6 mg |
| |8.4 Medicines used in palliative care |
|M-241-1002 |Amitriptyline |Tablet: 25 mg |
|M-195-0005 |Dexamethasone |Injection: 4 mg/ml |
|M-241-0010 |Diazepam |Injection: 10 mg. |
|M-241-1087 |Fluoxetine |Capsules: 20 mg |
|M-011-0015 |Midazolam |Injection: 5 mg/ml |
|M-022-9015 |Morphine |Injection: 10 mg/ml |
|M-182-1010 |Ondansetron HCl or a like |Tablet: 8 mg |
|M-182-0010 |Ondansetrone HCl or a like |Amp: 8 mg |
|9. Antiparkinsonism Medicines |
|M-071-1005 |Bromocriptine mesylate |Tablet: 2.5mg |
|M-071-1010 |Levodopa + Carbidopa |Tablet: 250 mg + 25 mg |
|M-071-1020 |Trihexephenidyl |Tablet: 2mg |
|M-071-1025 |Trihexephenidyl |Tablet: 5 mg |
|10. MEDICINES AFFECTING THE BLOOD |
| |10.1 Antianaemia medicines |
|M-111-0005 |Erythropiotin or alike |Injection: 2000 I.U |
|M-282-2014 |Ferrous sulfate |Solution: 50 mg/ ml elemental iron with a |
| | |dropper |
|M-282-1005 |Ferrous sulfate |Tablet: 160 mg |
|M-282-1015 |Ferrous sulfate + Folic acid |Tablet: 160 +400 mcg |
|M-281-1032 |Folic acid |Tablet: 5 mg |
|M-282-0010 |Ferrous sucrose complex |Injection: 100 mg /5mg IU |
|M-281-0020 |Hydroxycobalamin |Injection: 1000 mcg in 1‐ml |
| | |ampoule |
| |10.2 Medicines affecting coagulation |
|M-112-0006 |Enoxaparin prefilled syringes |Injection: 20 mg/ml |
|M-112-0007 |Enoxaparin prefilled syringes |Injection: 40 mg/ml |
|M-112-0008 |Enoxaparin prefilled syringes |Injection: 60 mg/ml |
|M-112-0009 |Enoxaparin prefilled syringes |Injection: 80 mg/ml |
|M-112-0005 |Heparin sodium |5000 IU/ml; 5 ml. |
|M-113-0008/10 |Phytomenadione |Injection: 2 mg/ 0.2 ml, 10 mg/ ml |
|M-113-0015 |Protamine sulfate |Injection: 10 mg/ml in 5‐ml ampoule |
|M-113-0000 |Tranexamic acid |Injection: 500 mg/ ampoule |
|M-113-1005 |Tranexamic acid |Tablet: 500 mg |
|M-112-1010 |Warfarin |Tablet: 5 mg (sodium salt) |
|M-112-1008 |Warfarin |Tablet:2 mg |
| |10.3 Other medicines for haemoglobinopathies |
|M-111-0005 |Erythropiotin |Injection:2000 IU/vial |
|11. BLOOD PRODUCTS AND PLASMA SUBSTITUTES |
| |11.1 Plasma substitutes |
|M-114-2005 |Haemaccel or alike |Solution: 500 ml |
| |11.2 Plasma fractions for specific use |
|M-116-0005 |Factor VIII |Vial |
|M-116-0006 |Factor IX complex |Vial |
|M-116-0009 |Normal Albumin (human serum ) |Injection: 20%. 50 mL |
|12. CARDIOVASCULAR MEDICINES |
| |12.1 Antianginal medicines |
|M-123-1005 |Atenolol |Tablet: 100 mg |
|M-123-1007 |Atenolol |Tablet: 25 mg |
|M-123-1018 |Bisoprolol |Tablet: 5 mg |
|M-121-0010 |Nitroglycerin |Injection: 50 mg / 10ml |
|M-121-1020 |Isosorbide Mononitrate |Tablet : 20 mg |
|M-121-1005 |Isosorbide Dinitrate |Tablet (sublingual): 5 mg |
|M-121-0015 |Propranolol HCl |Injection: 5 mg/2ML |
|M-121-1040 |Propranolol HCl |Tablet: 10 mg |
|M-121-1045 |Propranolol HCl |Tablet: 40 mg |
|M-121-1047 |Verapamil HCl |Tablet: 40 mg |
|M-121-1050 |Verapamil HCl |Tablet: 80 mg |
|M-121-0020 |Verapamil HCl |Injection: 5 mg /2 mL |
| |12.2 Antiarrhythmic medicines |
|M-122-0001 |Adenosine |Amp: 6 mg/ mL per 2 ml |
|M-122-1005 |Amiodarone HCl |Tablet: 200 mg. |
|M-122-0005 |Amiodarone |Injection: 150 mg / ampoule per 3ml |
|M-123-1018 |Bisoprolol |Tablet: 5 mg |
|M-124-2005 |Digoxin |Oral liquid (Elixir): 0.05 mg/ml. 60 mL. |
|M-124-1005 |Digoxin |Tablet: 0.25 mg |
|M-124-0005 |Digoxin |Injection: 0.5 mg/ml in 1‐ml ampoule |
|M-125-0020 |Isoprenaline HCl |Injection: 200 mcg/ml. 5ml |
|M-121-1047 |Verapamil HCl |Tablet: 40 mg |
| |12.3 Antihypertensive medicines |
|M-123-1004 |Amlodipine |Tablet: 5 mg |
|M-123-1007 |Atenolol |Tablet: 25 mg |
|M-123-1005 |Atenolol |Tablet: 100 mg |
|M-123-1018 |Bisoprolol |Tablet: 5 mg |
|M-123-1035 |Enalapril Maleate |Tablet: 5 mg |
|M-123-1030 |Enalapril Maleate |Tablet: 20 mg |
|M-123-1051 |Doxazosin |Tablet : 2 mg |
|M-123-1025 |Diltiazem |Tablet: 60 mg |
|M-123-0015 |Hydralazine |Amp: 20 mg |
|M-123-0050 |Labetalol |Injection: 100 mg/20 ml |
|M-123-1041 |Losartan |Tablet: 50 mg |
|M-123-1045 |Methyldopa |Tablet: 250 mg. |
|M-123-0005 |Sodium Nitroprusside |Powder for infusion: 50 mg in ampoule /2 ml |
| |12.4 Medicines used in heart failure |
|M-125-0005 |Adrenaline |Injection: 1mg/ml |
|M-123-1008 |Carvedilol |Tablet: 6.25 mg |
|M-123-1023 |Carvedilol |Tablet: 12.5 mg |
|M-124-2005 |Digoxin |Oral liquid (Elixir): 0.05 mg/ml |
|M-124-1005 |Digoxin |Tablet: 0.25 mg |
|M-124-0005 |Digoxin |Injection: 0.5 mg |
|M-125-0015 |Dopamine |Injection: 200 mg |
|M-125-0010 |Dobutamine |Injection: 250 mg\ vial |
|M-123-1035 |Enalapril Maleate |Tablet: 5 mg |
|M-123-1030 |Enalapril Maleate |Tablet: 20 mg |
|M-276-1020 |Furosemide |Tablet: 40 mg |
|M-276-0010 |Furosemide |Injection: 250 mg /ampoule |
|M-276-0005 |Furosemide |Injection: 20 mg in vial |
|M-276-1050 |Hydrochlorothiazide |Tablet: 25 mg |
|M-125-0025 |Phenylephrine HCL |Injection: 1% vial |
| |12.5 Antithrombotic medicines |
|M-129-1005 |Acetylsalicylic acid (Aspirin) |Tablet: 100 mg |
|M-112-1003 |Clopidogrel |Tablet: 75 mg. |
|M-129-0005 |Streptokinase |Powder for injection: 1.5 million IU in vial |
| |12.6 Lipid-lowering agents |
|M-301-1001 |Atrovastatin |Tablet: 40 mg |
|13. DERMATOLOGICAL MEDICINES (topical) |
| |13.1 Antifungal medicines |
|M-131-5020 |Miconazole |Cream: 2 % |
|M-131-5028 |Terbinafine |Cream: 1% |
| |13.2 Anti-infective medicines |
|M-133-5035 |Chloramphenicol |Ointment: 3%. 10 grams |
|M-133-5044/52 |Fusidic acid |Cream/ ointment : 2% |
|M-133-5037/32 |Gentamicin |Ointment& Cream : 0.1% |
|M-133-5045 |Silver sulfadiazine |Cream: 1% |
| |13.3 Anti-inflammatory and antipruritic medicines |
|M-132-5005/ |Betamethasone Valerate |Cream or ointment: 0.1% |
|M-132-2005 |Calamine+ Zinc oxide |Lotion: 15% + 5%. (100 mL) |
|M-132-5015 |Clobetasol propionatef |Ointment: 0.05 %. 25 grams |
|M-132-5023/ |Hydrocortisone acetate |Cream or ointment: 1%. |
| |13.4 Medicines affecting skin differentiation and proliferation |
|M-137-1010 |Acetretin |Capsule: 25 mg |
|M-133-5025/ |Benzoyl Peroxide |Gel or lotion: 5% w/w. 40 g. |
|M-135-2005 |Benzyl Benzoate |Lotion: 25% |
|M-132-5044 |Calcipotriol50 mcg/g + Betamethasone 0.5 mg/ g |gel: 50 mcg/ gm. |
|M-132-5043 |Calcipotriol 50 mcg/g + Betamethasone 0.5 mg/ g |Ointment |
|M-135-2010 |Permethrin |Shampoo: 1% (Anti lice) |
|M-139-5020 |Salicylic acid + Benzocaine in a colloidal base. |Solution: 10% + 2% |
|M-136-5092/94 |Urea |Cream or ointment: 5%; 10%. |
|14. DIAGNOSTIC AGENTS |
| |14.1 Ophthalmic medicines |
|M-142-10050 |Fluorescein |Eye drop: 1% (sodium salt) |
|M-224-3022 |Tropicamide |Eye drop: 0.5% |
| |14.2 Radiocontrast media |
|M-142-2004 |Barium sulfate 92.5% |Powder, 5 Kg. |
|M-142-0008 |Iopromide or alike |Injection: 0.769 gm\ ml- 100 ml in vial. |
|M-142-0023 |Sodium Amidotrizoate 100 mg/mL, Meglumine Amidotrizoate. 660|Oral Solution |
| |mg/mL (Gastrograffin) | |
|15. DISINFECTANTS AND ANTISEPTICS |
| |15.1 Antiseptics |
|M-091-2005 |Chlorhexidine |Scrub: 4%. |
|M-091-2010 |Chlorhexidine+ Cetrimide |Solution: 1.5% + 15%. |
|M-091-2022 |Ethyl Alcohol |Solution: 70% (denatured). |
|M-091-2030 |Povidone (Polyvidone Iodine) |Solution: 10% |
|M-091-2025 |Povidone |Scrub: 7.5% |
| |15.2 Disinfectants |
|M-091-1005 |Triclosene Sodium |Tablet : 2.5 g |
| |16. DIURETICS |
|M-276-0005 |Furosemide |Injection: 10 mg/ml in 2‐ml ampoule |
|M-276-1020 |Furosemide |Tablet: 40 mg |
|M-276-0010 |Furosemide |Injection :250 mg /ampoule |
|M-276-1050 |Hydrochlorothiazide |Tablet: 25 mg |
|M-292-2075 |Mannitol |Injectable solution: 20%. 500 mL |
|M-276-1025 |Spironolactone |Tablet: 100 mg |
|M-276-1024 |Spironolactone |Tablet: 25 mg |
|17. GASTROINTESTINAL MEDICINES |
| |17.1. Antacids & Antiulcer medicines |
|M-181-1010 |Aluminium hydroxide gel + Mg trisilicate |Tablet: 190 mg+ 330 mg |
|M-181-2005 |Aluminum +Magnesium hydroxide |Suspension: 200 ml |
|M-181-1015 |Calcium carbonate |Tab: 600 mg |
|M-181-0003 |Esomeprazole |Amp: 40 mg or Alike |
|M-181-1018 |Omeprazole |Tablet: 20 mg |
|M-181-1034 |Famotidine |Tablet: 20 mg mg |
| |Famotidine |Injection: 20 mg /2ml injection |
| |17.2 Antiemetic medicines |
|M-182-0005 |Metoclopramide HCl |Injection: 10 mg/ml in 2‐ml ampoule |
|M-182-1005 |Metoclopramide |Tabet: 10 mg |
|M-041-0005 |Promethazine |Amp: 50 mg/ml |
| |17.3 Anti-inflammatory medicines |
|M-183-1003 |5 - Aminosalisylic acid |Tablet: 500 mg |
| |17.4 Laxatives |
|M-185-1005 |Bisacodyl |Tablet : 5 mg |
|M-185-6010 |Glycerin |Pediatric supp: 1.4 grams |
|M-185-6015 |Glycerin |Adult supp: 2.7 grams |
|M-185-2004 |Lactulose + Galactose + Lactose |Syrup: 50% + 8% + 5% w/w. 100 mL |
|M-185-2015 |Sodium biphosphate + Sodium phosphate |Enema: 16 g + 6 g /100 ml. 250 ml |
| |17.5 Medicines used in diarrhea |
| |17.5.1 Oral rehydration |
|M-291-2006 |Oral rehydration salts powder |Powder for oral therapy |
| |17.6 Antispasmodics |
|M-184-1003 |Hyoscine-N- butylbromide |Tablet: 10 mg |
|M-184-0020 |Hyoscine-N- butylbromide |Injection: 20 mg /ampoule |
| |17.7 Hepato - billary drugs. |
|M-186-1005 |Pancreatin ( protease +lipase + amylase) |Capsule: 150 mg |
|18. HORMONES, OTHER ENDOCRINE MEDICINES AND CONTRACEPTIVES |
| |18.1 Adrenal hormones and synthetic substitutes |
|M-195-0005 |Dexamethasone |Injection: 4 mg |
|M-195-1005 |Dexamethasone |Tablet: 0.5 mg |
|M-195-1006 |Dexamethasone |Tablet: 2 mg |
|M-195-1010 |Fludrocortisone acetate |Tablet: 0.1 mg |
|M-195-1015 |Hydrocortisone |Tablet: 10 mg |
|M-195-0015 |Hydrocortisone |Injection: 100 mg/vial |
|M-195-0030 |Methylprednisonolone sodium succinate |Injection: 1 gram |
|M-195-0025 |Methylprednisolone acetate |Injection: 80 mg |
|M-195-1020 |Prednisolone |Tablet: 20 mg |
| |18.2 Contraceptives |
| |18.2.1 Oral hormonal contraceptives |
|M-196-1018 |Ethinylestradiol + Levonorgestrel |Tablet: 0.03 gram + 0.15 gram |
|M-196-1040 |levonorgestril |Tablet : 30 mcg |
| |18.2.2 Intrauterine devices |
|M-196-1055 |Copper‐ T |Device |
|M-196-1050 |Multiload |Device |
| |18.5 Insulin and other medicines used for diabetes |
|M-192-1012 |Glimepiride |Tablet: 2mg |
|M-192-1016 |Glimepiride |Tablet: 4 mg |
|M-193-0004 |Glucagon Lypholyzed |Vial: 1 mg |
|M-191-0005 |Insulin Actrapid HM. |Injection: 100 IU/ml .10‐ml vial |
|M-191-0010 |Insulin Human 30/70 |Injection: 100 U/ ml. 10 ml |
|M-191-0015 |Insulin NPH HM |Injection: 100 IU/ml in 10‐ml vial |
|M-192-1010 |Metformin |Tablet: 850 mg |
|M-191-0051 |Aspart | |
|M-191-0051 | Rapid acting insulin analogues (Aspart,Lispro,Glulisine) | |
|M-191-0075 | | |
|M-191-0080 |Long acting insulin analogues (Glargine,Detemir) | |
|M-191-0052 | | |
| |Sitagliptine |Tablet: 50,100 mg |
| |18.6 Ovulation inducers |
|M-197-1005 |Clomifene citrate |Tablet: 50 mg |
| |18.7 Progestogens |
|M-196-1020 |Medroxyprogesterone acetate |Tablet: 5 mg |
|M-196-1025 |Norethisterone |Tablet : 5 mg |
| |18.8 Thyroid & Anti-thyroid drugs |
|M-194-1005 |Methimazole |Tablet: 20 mg |
|M-194-1010 |Propylthiouracil |Tablet: 50 mg |
|M-194-1013 |Thyroxine (sodium salt) |Tablet: 50 micrograms |
|M-194-1015 |Thyroxine (sodium salt) |Tablet: 100 micrograms |
| |18.9 Others |
|M-199-0010 |Calcitonin (synthetic, salmon) |Injection :100 IU/inj |
|M-196-1015 |Danazol |Capsule: 200 mg. |
|M-103-0025 |Octreotide |Ampoule: 0.1 mg/ mL |
|M-198-0005 |Somatropin or alike |12 IU. |
|M-273-2006 |Desmopressin Acetate |Intranasal: 0.1 mg/ ml |
|M-273-1003 |Desmopressin Acetate |Tablet: 0.2 mg |
| |19. IMMUNOLOGICALS |
| |19.1 Diagnostic agents |
|E19101104 |Tuberculin, purified protein derivative (PPD) |Injection |
| |19.2 Sera and immunoglobulins |
|E19201116 |Antitetanus immunoglobulin (human) |Injection: 250 IU in vial |
|M-201-00 |Anti-snake venom serum |Injection |
|M-201-0009 |Anti-scorpion serum |Injection |
|E19201128 |Hepatitis B Immunoglobulin Serum |Injection(I.V): 2 ml |
|E19201124 |Hepatitis B Immunoglobulin Serum |Injection (I.M): 5 mL |
|M-201-0030 |Immunoglobulin G (human) |Infusion : 5%, 100 mL |
|M-201-0035 |Immunoglobulin Human Anti-D |Injection: 250 micrograms in single‐dose vial |
|E19201104 |Rabies immunoglobulin |Injection: 10 mL |
| |19.3 Vaccines |
|E19201104 |Anti-Rabic vaccine |Vial: 10 ml |
|E19301108 |BCG vaccine |Vial |
|E19301116 |Diphtheria + Tetanus (children) |Vial |
|E19301112 |Diphtheria + Tetanus( Adult) |Vial |
|E19301120 |Diphtheria + Tetanus + Pertussis |Vial |
|E19301124 |Hepatitis B vaccine |Adult |
|E19301128 |Hepatitis B vaccine |Infant |
|E19301132 |Measles vaccine |Vial |
|E19301140 |Measles +Mumps +Rubella (MMR) |Vial |
|E19301136 |Meningococcal meningitis vaccine |Vial |
|E19301161 |PENTA ( DTP+ HIB + HEP.B ) vaccine |Vial |
|E19301144 |Poliomyelitis vaccine (Polio Salk vaccine) |IM injection |
|E19301148 |Poliomyelitis vaccine (Polio Oral vaccine) |Oral |
|E19301152 |Rubella vaccine |Vial |
|E19301156 |Tetanus toxoid vaccine |Vial, 5 mL |
|E19301162 |Hemophillus Influenza Type B vaccine |Vial |
|E19301163 |Influenza Vaccine |Vial |
|20. MUSCLE RELAXANTS (PERIPHERALLY-ACTING) AND CHOLINESTERASE |
|INHIBITORS |
|M-211-0010 |Atracurium besylate |Injection: 10 mg/ml. 5 mL |
|M-211-1010 |Baclofen |Tablet: 25 mg |
|M-211-00 |Pancuronium Br + NaCl |Ampoule : 4 mg + 18 mg |
|M-272-1020 |Pyridostigmine Bromide |Tablet: 60 mg. |
|M-211-0025 |Suxamethonium HCl |Injection: 50 mg /ml in 2‐ml ampoule. |
|M-211-0030 |Vecuronium |Injection: 4 mg/ml vial |
|21. OPHTHALMOLOGICAL PREPARATIONS |
| |21.1 Anti-infective agents |
|M-228-5005 |Acyclovir |Eye Ointment: 4.5 g. |
|M-221-3007 |Gentamicin Sulphate |Solution (eye drops): 0.3%. |
|M-221-3003 |Chloramphenicol |Drop:0.5% |
|M-221-5007 |Oxytetracycline |Eye ointment: 0.05% |
| |21.2 Anti-inflammatory agents. |
|M-222-3008 |Dexamethasone |Drop: 0.1% |
|M-222-3006 |Tetrahydrozoline HCL |Drop: 0.05%, 10 ml |
| |21.3 Local anaesthetics |
|M-223-3005 |Benoxinate HCL |Eye drop: 0.4% |
| |21.4 Miotics and anti-glaucoma medicines |
|M-276-1005 |Acetazolamide |Tablet: 250 mg |
|M-224-3020/15 |Pilocarpine Nitrate |Solution (eye drops): 2% |
|M-224-3030 |Timolol |Solution (eye drops): 0.5% (as hydrogen |
| | |maleate) |
|M-224-3009 |Latanoprost or ALIKE |Eye drops |
| |21.5 Mydriatics | |
|M-224-3022 |Tropicamide |Eye Drop: 0.5% |
| |Cyclopentolate* |Eye Drop: 1% |
|M-224-3023 |Phenylephrine HCl |Eye Drop: 10%, 5 ml |
| |21.6 Tears deficiency medicines |
|M-226-5005 |Artificial eye gel |Gel |
|22. OXYTOCICS AND ANTIOXYTOCICS |
| |22.1 Oxytocics |
|M-231-0005 |Dinoprostone |Amp: 10 mg/ 1mL |
|M-231-1010 |Dinoprostone |Vaginal Tablet: 3 mg |
|M-231-0010 |Methylergotamine |Injection: 0.2 mg. 1 mL |
|M-231-1025 |Misoprostol |Tablet: 200 micrograms. |
|M-231 |Misoprostol |Vaginal tablet: 25 micrograms |
|M-231-0015 |Oxytocin |Injection: 10 IU in 1‐ml |
|23. Dialysissolution |
|E23004708 |Hemodialysis fluid Acidic component |Solution |
|E23004704 |Hemodialysis conc bicarbonate D 326 |Solution |
|E23004712 |Peritonial dialysis dextrose |Solution: 1.5%. 1L |
|E23004716 |Peritonial dialysis dextrose |Solution: 1.5%. 2L |
|E23004720 |Peritonial dialysis dextrose |Solution: 4.25%. 1L |
|E23004724 |Peritonial dialysis dextrose |Solution: 4.25%. 2L |
|24. MEDICINES FOR MENTAL AND BEHAVIOURAL DISORDERS |
| |24.1 Medicines used in psychotic disorders |
|M-241-0005 |Chlorpromazine HCl |Injection: 50 mg/ml in 2‐ml ampoule |
|M-241-1040 |Chlorpromazine HCl |Tablet: 100 mg |
|M-241-1081 |Clozapine |Tablet: 25 mg |
|M-241-1083 |Clozapine |Tablet: 100 mg |
|M-241-1024 |Citalopram |Tablet: 20 mg |
|M-241-1064 | escitalopram 10mg | |
|M-241-0019 |Fluphenazine decanoate |Injection: 25 mg in 1‐ml ampoule. |
|M-241-0025 |Haloperidol |Injection: 5 mg in 1‐ml ampoule |
|M-241-1065 |Haloperidol |Tablet: 5 mg |
|M-241-0030 |Haloperidol decanoate |Injection: 100 mg |
|M-241-1102 |Olanzapine | Vello Tablet: 5 mg |
|M-241-1106 |Quetiapine |Tablet: 200 mg |
|M-241-1113 |Risperidone |Tablet: 2 mg |
| |24.2.1 Medicines used in depressive disorders |
|M-241-1002 |Amitriptyline |Tablet: 25 mg (hydrochloride) |
|M-241-1087 |Fluoxetine HCl |Cap: 20 mg |
| |24.2.2 Medicines used in bipolar disorders |
|M-051-1005 |Carbamazepine |Tablet: 200 mg. |
|M-241-1090 |Lithium carbonate |Solid oral dosage form: 300 mg. |
| |24.3 Medicines for anxiety disorders |
|M-241-1005 |Alprazolam |Tablet: 0.25 mg |
|M-241-1055 |Diazepam |Tablet (scored): 5 mg |
|M-241-0010 |Diazepam |Injection: 5 mg /ml. 2 ml. |
| |24.4 Medicines used for obsessive compulsive disorders |
|M-241-1030 |Clomipramine HCl |Capsule: 25 mg. |
|M-241-1087 |Fluoxetine |Capsule: 20 mg. |
|M-241-1080 |Imipramine |Tablet :25 mg. |
| |24.5 Others | |
|M-241-1140 |Methylphenidate |Tablet: 10 mg |
|25. MEDICINES ACTING ON THE RESPIRATORY TRACT |
| |25.1 Anti-asthmatic medicines |
|M-251-0005 |Aminophylline |Injection : 250 mg |
|M-251-4014 |Budesonide |Aerosol: 200 micrograms |
|M-251-4011 |Budesonide |Aerosol: 400 micrograms |
|M-251-1008/4030 |Formoterol Fumarate |Aerosol: 12 micrograms |
|M-251-4013 |Ipratropium bromide |Inhalation (aerosol): 20 micrograms/metered |
| | |dose |
|M-251-2012 |Ipratropium bromide |Solution for nebulization 0.25 mg/mL. 20 mL. |
|M-251-4012 |Salbutamol Sulphate |Inhalation (aerosol): 100 micrograms per dose |
|M-251-2015 |Salbutamol Sulphate |Respiratory solution for use in nebulizers: 5 |
| | |mg/ml |
|M-251-1005 |Salbutamol |Tablet: 2 mg |
|M-251-2010 |Salbutamol |Syrup: 2 mg/5 ml. 150 ml. |
|M-251-0012 |Salbutamol |Amp: 0.5 mg/ml |
|M-251-1015 |Theophylline |Tablet: 100 mg |
|M-251-1020 |Theophylline |Tablet: 300 mg |
|26.Solutions correcting water, electrolyte and acid -base |
| |26.1 Oral |
|M-291-2010 |Oral rehydration salts |Powder |
| |26.2 Parenteral |
|M-312-2034 |Aminoacid 10% for Adult |Solution : 500 ml |
|M-312-2003 |Aminoacid 10% for Neonates |Solution |
|M-292-2010 |Dextrose |Injectable solution: 5% (isotonic). 1 L. |
|M-292-2015 |Dextrose |Injectable solution: 10% (hypertonic) |
|M-292-2025 |Dextrose |Injectable solution: 50% (hypertonic). |
|M-292-2020 |Dextrose |Injectable solution: 20% |
|M-292-2005 |Dextrose + Saline |Injectable solution: 5% + 0.9%. 500 ml. |
|M-292-2065 |Dextrose + Saline |Injectable solution: 4.3% + 0.18%. 500 ml. |
|M-312-2030 |Intralipid 20% |500 ml |
|M-292-2030 |Glycine irrigation |Solution: 1.5 % |
|M-292-2035 |Lactated Ringer |Solution. 500 ml. |
|M-292-0004 |Potassium chloride |Injection: 15%. 10 ml. |
|M-292-0005 |Sodium bicarbonate |Vial= 8.4%, 100ml |
|M-292-0001 |Saline |Vial: 23.4%; 30 ml. |
|M-292-2040 |Saline |Solution: 0.45%. 500 ml |
|M-292-2047/50 |Saline |Solution : 0.9% 100 ml or 150ml |
|M-292-2055 |Saline |Solution : 0.9% 500 ml |
|M-292-2060 |Saline |Solution : 0.9% 3000 ml |
| |Saline |Solution : 0.9% 250 ml |
| |26.3 Miscellaneous |
|M-331-0015 |Water for injection (Distilled water) |10‐ml ampoules. |
|27. VITAMINS, MINERALS AND OTHER NUTRITIONAL SUPPLEMENTS |
| |27.1. Vitamins and Minerals |
|M-281-3010 |Alfacalcidol |Drops: 0.25 mcg/ drop. |
|M-281-1010 |Alfacalcidol |Capsule :0.25 mcg |
|M-281-1015 |Alfacalcidol |Capsule : 1 mcg |
|M-282-0005 |Calcium Gluconate |Injection: 10%. 10 ml |
|M-281-1045 |Vit B6 |100 mg/ampoule |
|M-281-2005 |Vit A as palmitate + Vit D2 |Drop : 500 U+ 200 U/ Drop |
| |27.2 Nutritional Supplements |
|M-312-2005 |Ensure |liquid:240ml |
| |Extensively hydrolyzed cow milk protein |Powder |
|M-311-8028 |Phenylalanine- free formula for infants |Powder |
|M-311-8019 |Phenylalanine- free formula for children |Powder |
|M-311-8035 |Premature formula milk |Powder |
|M-311-8040 | soya protein based formula. |Powder |
|28- EAR, NOSE and THROAT |
|M-171-4020 |Budesonide |Liquid Nasal Spray |
|M-171-3055/60 |Xylometazoline |0.05% & 0.1% Nasal spray |
|M-171-3050 |Ciprofloxacin Topical (Otic) or alike |Ear Drops 0.35% 5ml |
|M-161-1006 |Betahistine |Tablet: 16 mg |
|29. SPECIFIC MEDICINES FOR NEONATAL CARE |
|M-231-0004 |Alprostadil (PGE1) |Solution for Injection: 0.5 mg/ ml. |
|M-253-0007 |Caffeine citrate |Injection: 20 mg/ml (equivalent to 10 mg |
| | |caffeine base/ml). |
|M-253-2030 |Caffeine citrate |Oral liquid: 20 mg/ml (equivalent to 10 mg |
| | |caffeine base/ml). |
|M-253-0015 |Surfactant (phospholipid + protein ) |Vial: 6 ml. |
|30.DRUG AFFECTING U.T.S |
| |30.1 NOCTURNAL ENURESIS | |
|M-241-1080 |Imipramine |Tablet: 25MG |
|M-273-1005 |Oxybutynin HCL |Tablet: 5MG |
Complementary Drug List ( CDL)
| | |Drug |Strength / Dosage Form |Category |
| |M-101-1050 |ATRA (Al Trans Retinoic Acid, Tretinoid) |Cap 10 mg |Chemotherapy |
| |M -111-0025 |Erythropiotein beta |30.000 unit | chemotherapy |
| |M-024-0005 |Etanarcept 25mg/ml |25mg/ml |RA |
| |M-024-0025 |Etanarcept 50mg/ml |50mg/ml | |
| |M-024-0020 |Adalimumab |40mg/0.8ml |RA+CHRONS D |
| |M-032-1050 |Sevelamir |800mg tab | |
| |M-085-1000 |Valganciclovir |450mg tab |GMV |
| |M-101-0023/24 |Bevacizumab |100and400mg/vial |cancer |
| |M-101-0026 |Bortezomib |3.5mg vial |cancer |
| |M-101-0094 |Rituximab |500mg/50ml vial |cancer |
| |M-101-0097 |Rituximab |100mg/10ml vial |cancer |
| |M-101-0098 |trastuzumab |440mg vial |cancer |
| | |trastuzumab |600 mg/5ml |cancer |
| |M-101-1043 |thalidomide |50mg tab |cancer |
| |M-103-0010 |triptoreline |3.75mg amp |Precousious puperty |
| |M-103-0026 |octreotide |20mg amp |acromegaly |
| |M-105-0040 |basiliximab |20mg vial |Kidney transplant |
| |M-186-1011 |Ursodeoxycholic acid |300mg caplet |Liver disease |
| |M-211-0023 |Purified botulinum atoxin |vial | |
| |M-225-0005 |Acetylcholine chloride |20mg vial |Ophthalmology |
| |M-225-0080 |Sodium hyaluronate |0.85ml |Ophthalmology |
| |M-229-3010 |cyclosporin |0.05 e/d |Ophthalmology |
| |M-311-8010 |Glucose-Galactose intolerance based formula |powder |Metabolic disorders |
| |M-311-8021 |Msud analog(infants)formula |single |Metabolic disorders |
| |M-311-8036 |Msud maximaid(children1-8y)formula |single |Metabolic disorders |
| |M-311-8055 |Methionine – threonine – valine – free and low|single |Metabolic disorders |
| | |– isoleucine formula (less than 1 year) | | |
| |M-311-8056 |Methionine – threonine – valine – free and low|single |Metabolic disorders |
| | |– isoleucine formula (1-8 years) | | |
| |M-311-8060 |Phenylalanine – tyrosine free formula(0-1 |single |Metabolic disorders |
| | |year) | | |
| |M-311-8065 |Phenylalanine – tyrosine free formula(1-8 |single |Metabolic disorders |
| | |year) | | |
| |M-312-2010 |L-carnitine 30%20ml |30%20ml sol |Metabolic disorders |
| |M-311-8022 |Amino acid-based formula(0-12 months of age) |Single |Metabolic disorders |
| |M-311-8026 |Amino acid-based formula(over 1 year of age) |100mg sachet* |Metabolic disorders |
| |M-311-8039 |(Low LCT- high MCT) formula milk |Single |Metabolic disorders |
| |M-282-8005 |sodium polystyrene sulfonate |powder for suspension | |
| |M-105-1040 |Sirolimus 1mg |Cap | |
| |M-312-1050 |Glycin 500 mg |Cap | |
| |M-071-1007 |Cabergoline 0.5mg |tab | |
| |M-360-8010 |Betaine 1gm/teaspoon |Powder 180gm bottle | |
| |M-312-1001 |Arginine 500mg |Cap | |
| |M-022-9014 |Methadone HCL 50mg/ml |SOLUTION 200ML | |
| |M-150-0080 |Velaglucerase alpha 400u Vial |Single | |
| | |or Taliglucerase 200 unit Vial | | |
| |M-292-2032 |Plasma-Lyte soln |solution | |
| |M-225-0085 |Sodium Hyaluronate Opth. 14 Mg | | |
| | | |Injection | |
| |M-142-0090 |Tryban Blue opth. soln 0.06% | | |
| | | |Injection | |
| |M-225-0041 |Riboflavin Regular 3 cc | | |
| | | |solution | |
| |M-225-0043 |Riboflavin Hypotonic 1.5 cc | | |
| | | |solution | |
| |M-101-0092 |Pamidronate disodium 30 mg | | |
| | | |Injection | |
| |M-051-1026 |Levetiracetam 500 mg |Tab | |
| |M-051-2007 |Levetiracetam 100 mg / ml |Solution |Epilepsy |
| |M-105-1035 |Leflunamide 20 mg |Tab |Rheumatoid arthritis |
| | |Alteplase 50 mg |Injection | |
................
................
In order to avoid copyright disputes, this page is only a partial summary.
To fulfill the demand for quickly locating and searching documents.
It is intelligent file search solution for home and business.